Clinical Trials Logo

Clinical Trial Summary

Plasma concentration data were collected from 37 paedriatic patients and 12 healthy adults recruited in a single dose, open-label phase II pharmacokinetic study and in a single dose, randomised, open-label two-peiod crossover bioavailability study, respectively. Data were analysed using non-linear mixed effect modeling.


Clinical Trial Description

In the absence of a licensed formulation in many countries worldwide, ADV6209, an innovative 2mg/ml oral solution of midazolam containing cyclodextrin, has been developed for moderate sedation in paediatric patients. Population pharmacokinetics for ADV6209 is reported.

Plasma concentration data were collected from 37 paedriatic patients and 12 healthy adults recruited in a single dose, open-label phase II pharmacokinetic study and in a single dose, randomised, open-label two-peiod crossover bioavailability study, respectively. Data were analysed using non-linear mixed effect modeling. Plasma concentrations of midazolam were discribed by a two-compartement model. An additional one-compartement model was added for a α-hydroxymidazolam. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03639428
Study type Observational
Source Centre Hospitalier Universitaire, Amiens
Contact
Status Completed
Phase
Start date June 23, 2011
Completion date November 30, 2017

See also
  Status Clinical Trial Phase
Recruiting NCT01256866 - Sedation of Mechanically Ventilated Critically Ill Patients: Midazolam Versus Dexmedetomidine Phase 4
Not yet recruiting NCT06407518 - Preoperative Oral Midazolam to Postoperative Pain Relief in Sleep Disturbance or Anxiety Patients With Colorectal Cancer N/A
Recruiting NCT05192629 - Intranasal Dexmedetomidine Versus Oral Midazolam as Premedication for Propofol Sedation in Pediatric Patients Undergoing Magnetic Resonance Imaging Phase 3
Recruiting NCT04729478 - Comparison Between Natural Sleep Endoscopy and Drug-induced Sleep Endoscopy in Patients With Obstructive Sleep Apnea N/A
Not yet recruiting NCT06275594 - Trial Evaluating the Efficacy of Remimazolam in Endobronchial Ultrasound Guided Transbronchial Needle Aspiration Phase 2
Completed NCT05942365 - A Drug Interaction Study Assess the Effects of ZSP1273 Tablets on the Pharmacokinetics of Warfarin and Midazolam Phase 1
Completed NCT04068948 - Comparing Pediatric Dental Oral Sedation Outcomes With and Without Meperidine in Children Aged 3-7 Years Phase 4
Completed NCT04718259 - The Use of Midazolam as Adjuvant to Bupivacaine Intrathecal Anesthesia for Children Undergoing Lower Abdominal Surgeries. Early Phase 1
Completed NCT03397069 - Midazolam Additive to Local Anesthetic in Peribulbar Block N/A
Completed NCT03030911 - Dexmedetomidine vs Midazolam on Resting Energy Expenditure in Critically Ill Patients Phase 4
Completed NCT05371600 - Preoperative Anxiolysis With Intravenous Midazolam on Intraoperative Sevoflurane Gas Consumption Phase 4
Completed NCT04652661 - Intranasal Dexmedetomidine Versus Intranasal Midazolam for MRI In Pediatrics Phase 4
Not yet recruiting NCT06018207 - ED50 of Midazolam Oral Solution for Preoperative Hypnosis in Adults : An Up-and-Down Sequential Allocation Trial N/A
Recruiting NCT05485519 - Prospective, Randomized, Open Label Controlled Trial To Evaluate The Safety And Efficacy Of Dexmedetomidine Use Beyond 24 Hours Compared With Midazolam In Children Admitted To Pediatric Intensive Care Unit at King Abdullah Specialist Children Hospital- Ministry of National Guard Health Affairs. Phase 3
Completed NCT04656964 - Comparison Between Remimazolam Tosilate and Midazolam in Elderly Patients Undergoing Gastrointestinal Endoscopy N/A
Completed NCT04602845 - Remimazolam Tosilate Sedation and Midazolam Sedation in Dental Patients Phase 4